During the last three months, 5 analysts shared their evaluations of Ardent Health Partners ARDT, revealing diverse outlooks from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $21.6, along with a high estimate of $22.00 and a low estimate of $21.00. Highlighting a 4.0% decrease, the current average has fallen from the previous average price target of $22.50.

Exploring Analyst Ratings: An In-Depth Overview

The analysis of recent analyst actions sheds light on the perception of Ardent Health Partners by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Ardent Health Partners. This insight gives a snapshot of analysts' perspectives on the current state of the company.
• Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Ardent Health Partners compared to the broader market.
• Price Targets: Analysts predict movements in price targets, offering estimates for Ardent Health Partners's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

For valuable insights into Ardent Health Partners's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.

Stay up to date on Ardent Health Partners analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Unveiling the Story Behind Ardent Health Partners

Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services predominantly through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operate across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.

Ardent Health Partners's Financial Performance

Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

Revenue Growth: Ardent Health Partners's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 19.33%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 7.11%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): Ardent Health Partners's ROE stands out, surpassing industry averages. With an impressive ROE of 10.69%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): Ardent Health Partners's ROA excels beyond industry benchmarks, reaching 2.34%. This signifies efficient management of assets and strong financial health.

Debt Management: Ardent Health Partners's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 2.02.

What Are Analyst Ratings?

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.